Arvaya Healthcare Reports Non-Applicability of Fund Deviation Statement for Q2 FY27
Bijoy Hans Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 12:41 am
Arvaya Healthcare Reports Non-Applicability of Fund Deviation Statement for Q2 FY27 Arvaya Healthcare Limited (formerly Bijoy Hans Limited, BSE: 524723) informed the exchange that the Statement of Deviation(s) or Variation(s) in fund utilization under Regulation 32 of SEBI LODR Regulations is not applicable to the company for the quarter ended 30th Sep'26. Managing Director Kaushal Shah confirmed the compliance submission on 13th Nov'26.
Original exchange filing (PDF)
More announcements from Bijoy Hans Ltd
- The investor call arranged by the company on 16th November,2026 was concluded successfully. Please find attached herewith Audio for the same. 路 17 Nov 2026
- Investor Presentation in relation with the Unaudited Standalone and consolidated Financial Results of the Company for the quarter and half year ended on September 30 2026 and overall company .... 路 16 Nov 2026
- Unaudited Standalone and Consolidated financial results for the quarter ended 30th September 2026 路 14 Nov 2026
- Declaration of Unaudited standalone and consolidated Financial Results for the half year ended and 2nd quarter ended 30th September 2026 路 14 Nov 2026
- Revision in intimation and In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known .... 路 16 Nov 2026
- In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known as Bijoy Hans Limited) (''the .... 路 16 Nov 2026
- Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to the provisions .... 路 13 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 , the committee has approved and adopted the Draft Letter of Offer. 路 07 Nov 2026
